Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | geminin | 0.0166 | 0.343 | 1 |
Echinococcus granulosus | geminin | 0.0166 | 0.343 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0275 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0841 | 0.0841 |
Leishmania major | pteridine reductase 1 | 0.0026 | 0 | 0.5 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0026 | 0 | 0.5 |
Trichomonas vaginalis | hypothetical protein | 0.0385 | 0.8816 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0434 | 1 | 1 |
Trypanosoma brucei | oxidoreductase-like protein | 0.0026 | 0 | 0.5 |
Leishmania major | 3-oxoacyl-ACP reductase, putative | 0.0026 | 0 | 0.5 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.0224 | 0.0254 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0275 | 1 |
Brugia malayi | Bromodomain containing protein | 0.0035 | 0.0224 | 0.0224 |
Echinococcus multilocularis | Protein lozenge | 0.0054 | 0.0694 | 0.2024 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.0562 | 0.1639 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.0385 | 0.8816 | 1 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 0.219 | 0.6383 |
Brugia malayi | jmjC domain containing protein | 0.0043 | 0.0405 | 0.0405 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0037 | 0.0275 | 0.0803 |
Chlamydia trachomatis | enoyl-acyl-carrier protein reductase | 0.0385 | 0.8816 | 1 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0405 | 0.1182 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.0562 | 0.1639 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0275 | 0.0803 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0035 | 0.0224 | 0.0652 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.0224 | 0.0652 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0.0224 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0166 | 0.343 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0224 | 0.0224 |
Leishmania major | oxidoreductase-like protein | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0043 | 0.0405 | 0.0405 |
Brugia malayi | jmjC domain containing protein | 0.0115 | 0.219 | 0.219 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0049 | 0.0557 | 0.0557 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.0385 | 0.8816 | 1 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.1144 | 0.1144 |
Trypanosoma brucei | beta-ketoacyl-ACP reductase | 0.0026 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.0385 | 0.8816 | 1 |
Brugia malayi | PHD-finger family protein | 0.0035 | 0.0224 | 0.0224 |
Loa Loa (eye worm) | runx1 | 0.0054 | 0.0694 | 0.0694 |
Schistosoma mansoni | lozenge | 0.0054 | 0.0694 | 0.2024 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0035 | 0.0224 | 0.0652 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0.0224 | 0.0254 |
Trypanosoma cruzi | oxidoreductase-like protein, putative | 0.0026 | 0 | 0.5 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.0385 | 0.8816 | 1 |
Onchocerca volvulus | Alhambra homolog | 0.0035 | 0.0224 | 0.0224 |
Schistosoma mansoni | hypothetical protein | 0.0166 | 0.343 | 1 |
Onchocerca volvulus | 0.0434 | 1 | 1 | |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0224 | 0.0254 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.0405 | 0.1182 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0035 | 0.0224 | 0.0224 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0037 | 0.0275 | 0.0803 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0043 | 0.0405 | 0.1182 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.0224 | 0.0254 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 0.219 | 0.6383 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0035 | 0.0224 | 0.0652 |
Loa Loa (eye worm) | hypothetical protein | 0.0434 | 1 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.1608 | 0.4688 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0049 | 0.0557 | 0.0557 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0275 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0033 | 0.0178 | 0.0178 |
Echinococcus multilocularis | peregrin | 0.0035 | 0.0224 | 0.0652 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.0557 | 0.0557 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.0385 | 0.8816 | 1 |
Echinococcus granulosus | peregrin | 0.0035 | 0.0224 | 0.0652 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0026 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0033 | 0.0178 | 0.0178 |
Entamoeba histolytica | hypothetical protein | 0.0037 | 0.0275 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0033 | 0.0178 | 0.052 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0049 | 0.0557 | 0.0557 |
Leishmania major | dehydrogenase/oxidoreductase-like protein | 0.0026 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0037 | 0.0275 | 0.0803 |
Trypanosoma brucei | pteridine reductase 1 | 0.0026 | 0 | 0.5 |
Trypanosoma cruzi | beta-ketoacyl-ACP reductase | 0.0026 | 0 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0043 | 0.0405 | 0.1182 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.0385 | 0.8816 | 1 |
Brugia malayi | hypothetical protein | 0.0037 | 0.0275 | 0.0275 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.0385 | 0.8816 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.